These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7906192)

  • 21. The coexistence of parkinsonism-like symptoms and tardive dyskinesia.
    Richardson MA; Craig TJ
    Am J Psychiatry; 1982 Mar; 139(3):341-3. PubMed ID: 6120656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parkinsonism during lithium use].
    Walrave TR; Bulens C
    Tijdschr Psychiatr; 2009; 51(2):123-7. PubMed ID: 19194854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and instrumental assessment of neuroleptic-induced parkinsonism in patients with tardive dyskinesia.
    Caligiuri MP; Lohr JB; Bracha HS; Jeste DV
    Biol Psychiatry; 1991 Jan; 29(2):139-48. PubMed ID: 1671645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tardive Parkinsonism, orofacial dyskinesia and akathisia following brief exposure to lithium carbonate.
    Muthane UB; Prasad BN; Vasanth A; Satishchandra P
    J Neurol Sci; 2000 May; 176(1):78-9. PubMed ID: 10960299
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of persistent myoclonic tardive dystonia with verapamil.
    Abad V; Ovsiew F
    Br J Psychiatry; 1993 Apr; 162():554-6. PubMed ID: 8097657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use.
    Abraham JT; Brown R; Meltzer HY
    Biol Psychiatry; 1997 Jul; 42(2):144-6. PubMed ID: 9209732
    [No Abstract]   [Full Text] [Related]  

  • 30. Tardive dyskinesia in bipolar affective disorder: relationship to lithium therapy.
    Dinan TG; Kohen D
    Br J Psychiatry; 1989 Jul; 155():55-7. PubMed ID: 2575003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pisa syndrome].
    García C
    Nervenarzt; 1992 Jul; 63(7):434-9. PubMed ID: 1354332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of manual dominance in patients with neuroleptic-induced movement disorders.
    Kern RS; Green MF; Satz P; Wirshing WC
    Biol Psychiatry; 1991 Sep; 30(5):483-92. PubMed ID: 1681944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
    Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
    J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population.
    Bush G; Petrides G; Francis A
    Schizophr Res; 1997 Oct; 27(1):83-92. PubMed ID: 9373898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent tardive dyskinesia in bipolar patients.
    Mukherjee S; Rosen AM; Caracci G; Shukla S
    Arch Gen Psychiatry; 1986 Apr; 43(4):342-6. PubMed ID: 2869742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
    Normann C; Brandt C; Berger M; Walden J
    Pharmacopsychiatry; 1998 Sep; 31(5):201-4. PubMed ID: 9832353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for neuroleptic-induced movement disorders.
    Sandyk R; Kay SR; Awerbuch GI; Iacono RP
    Int J Neurosci; 1991 Dec; 61(3-4):149-88. PubMed ID: 1688114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.